Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$517M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$516M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$306M |
| 4 |
Meta Platforms (Facebook)
META
|
+$296M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$441M |
| 2 |
Duke Energy
DUK
|
+$407M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.71% |
| 2 | Financials | 4.45% |
| 3 | Healthcare | 3.9% |
| 4 | Communication Services | 2.83% |
| 5 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
3001
CALL
Dauch Corp
DCH
$1.35B
| $724K | ﹤0.01% |
37,500
+26,500
| +241% | +$449K |
|
3002
National Health Investors
NHI
$3.65B
| $724K | ﹤0.01% |
9,747
+3,171
| +48% | +$233K |
|
|
INFN
3003
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $724K | ﹤0.01% |
85,300
-59,800
| -41% | -$512K |
|
|
HMHC
3004
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $722K | ﹤0.01% |
66,579
+63,569
| +2,112% | +$745K |
|
3005
PUT
Ashland
ASH
$3.32B
| $721K | ﹤0.01% |
13,490
-68,270
| -84% | -$3.75M |
|
|
ACH
3006
Accendra Health
ACH
$224M
| $721K | ﹤0.01% |
20,446
+5,958
| +41% | +$201K |
|
3007
Wipro
WIT
$19.7B
| $721K | ﹤0.01% |
397,648
-13,840
| -3% | -$24.8K |
|
|
ISEE
3008
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $721K | ﹤0.01% |
149,200
+83,900
| +128% | +$2.49M |
|
|
FBC
3009
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $721K | ﹤0.01% |
26,728
+10,439
| +64% | +$288K |
|
3010
Corcept Therapeutics
CORT
$11.7B
| $719K | ﹤0.01% |
99,000
+49,541
| +100% | +$388K |
|
3011
Lumentum
LITE
$65.2B
| $719K | ﹤0.01% |
18,580
-6,738
| -27% | -$268K |
|
|
GGP
3012
PUT
DELISTED
GGP Inc.
GGP
| $719K | ﹤0.01% |
28,800
-4,000
| -12% | -$102K |
|
3013
Nordson
NDSN
$17.2B
| $718K | ﹤0.01% |
6,401
-22
| -0.3% | -$2.3K |
|
3014
PUT
Boston Properties
BXP
$11B
| $717K | ﹤0.01% |
5,700
+4,600
| +418% | +$572K |
|
3015
Lamb Weston
LW
$7.16B
| $717K | ﹤0.01% |
+18,971
| New | +$647K |
|
|
SAVE
3016
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $717K | ﹤0.01% |
12,400
+9,000
| +265% | +$464K |
|
3017
MGP Ingredients
MGPI
$371M
| $716K | ﹤0.01% |
14,321
+11,909
| +494% | +$529K |
|
3018
CALL
Marvell Technology
MRVL
$189B
| $716K | ﹤0.01% |
51,600
+1,300
| +3% | +$17.7K |
|
3019
CALL
VeriSign
VRSN
$26.4B
| $715K | ﹤0.01% |
9,400
-12,400
| -57% | -$980K |
|
|
DCT
3020
DELISTED
DCT Industrial Trust Inc.
DCT
| $715K | ﹤0.01% |
14,929
+7,699
| +106% | +$355K |
|
3021
Diana Shipping
DSX
$312M
| $714K | ﹤0.01% |
338,329
-246
| -0.1% | -$503 |
|
|
CTXS
3022
PUT
DELISTED
Citrix Systems Inc
CTXS
| $714K | ﹤0.01% |
10,046
-1,256
| -11% | -$86.8K |
|
3023
Alto Ingredients
ALTO
$349M
| $713K | ﹤0.01% |
75,068
+64,203
| +591% | +$516K |
|
3024
Healthcare Realty
HR
$6.92B
| $713K | ﹤0.01% |
24,471
+13,345
| +120% | +$393K |
|
3025
CALL
Nordic American Tanker
NAT
$1.36B
| $713K | ﹤0.01% |
85,579
+48,081
| +128% | +$427K |
|
Similar funds
Barclays's Q4 2016 Portfolio in Review
As of Q4 2016, Barclays held 7,178 positions worth $92.5B, up 2.7% from $90.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays's Q4 2016 filing shows 490 new, 3,383 increased, 2,405 reduced and 438 closed positions. Its largest new stake was Howmet Aerospace: 1,639,920 shares worth $23.3M. The largest sale was Procter & Gamble, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q4 2016 buy was Howmet Aerospace: 1,639,920 shares worth $23.3M.
- Barclays added most to State Street Technology Select Sector SPDR ETF in Q4 2016, an estimated $517M increase.
- Barclays's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $441M.
- Barclays fully exited LinkedIn Corporation in Q4 2016, selling an estimated $223M.
- Barclays's ten largest holdings make up 34% of its $92.5B portfolio in Q4 2016.
- Barclays opened 490 new positions and closed 438 in Q4 2016.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $92.5B.
Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.